.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Musculoskeletal ultrasound in PsA has revolutionized the way clinicians manage psoriatic disease. Because psoriatic arthritis often presents with diverse clinical signs, early diagnosis remains a significant challenge for many physicians. There are no definitive serological biomarkers available for this condition. Therefore, imaging plays a critical role in identifying early structural and inflammatory changes. Specifically, ultrasound allows doctors to see subclinical synovitis and enthesitis before physical symptoms appear. This early detection is vital for disease interception and prevention.
Notably, ultrasound detects various musculoskeletal involvements across the psoriatic spectrum. It identifies peritendonitis, tenosynovitis, and bursitis with high sensitivity. Moreover, it helps in the differential diagnosis between inflammatory and non-inflammatory joint pain. For instance, clinicians can distinguish between degenerative changes and active psoriatic inflammation. Furthermore, new scoring systems like the DUET score have improved the accuracy of enthesitis assessment. Consequently, these tools support a more precise and timely diagnosis.
Beyond diagnosis, ultrasound serves as a powerful prognostic tool. It predicts future structural damage by identifying active subclinical inflammation. Consequently, this information helps rheumatologists tailor treatment plans to individual patient needs. Additionally, ultrasound is highly effective for monitoring therapeutic response. By observing changes in power Doppler signals, physicians can objectively measure the success of biological therapies. This approach ensures that patients reach their treatment targets faster. Therefore, integrating ultrasound into routine practice promotes a precision medicine approach.
Subclinical psoriatic arthritis describes a phase where psoriasis patients show ultrasound evidence of inflammation, such as enthesitis, without having visible clinical symptoms. Early identification during this stage may prevent progression to established arthritis.
Ultrasound allows clinicians to visualize inflammatory activity that clinical exams might miss. By monitoring power Doppler signals, doctors can determine if a specific drug effectively reduces inflammation or if they need to switch therapies.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult a qualified medical practitioner for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
D'Ignazio E et al. The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring. Curr Rheumatol Rep. 2026 Jun 12. doi: undefined. PMID: 42277548.
Russu E, et al. The role of musculoskeletal ultrasonography in the early diagnosis and differentiation of rheumatoid arthritis, psoriatic arthritis and cutaneous psoriasis. Medical Research Archives. 2025;13(4). doi: 10.18103/mra.v13i4.6488.
RheumNow. New Advances in Ultrasound Diagnostics for Psoriatic Arthritis - ACR Convergence 2025. Published October 25, 2025.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Musculoskeletal ultrasound is essential for managing Psoriatic Arthritis (PsA). It helps doctors detect early subclinical changes, monitor treatment response, and provide personalized care. This review highlights how imaging improves diagnostic accuracy and long-term outcomes in psoriatic disease.
4 months ago
The TREM-AB open-label pilot study evaluated a wearable passive nonlinear vibration absorber for essential tremor. The Nonlinear Energy Sink bracelet reduced clinical Fahn-Tolosa-Marin tremor scores by 32.1% and electrophysiological tremor power by 49.2% with no adverse effects reported.
Today
A study in JAMIA Open shows lightweight open-source reasoning LLMs achieve up to 95% sensitivity and accelerate evidence synthesis screening by nearly twentyfold, presenting a cost-effective, scalable AI solution for biomedical research and systematic reviews.
Today
A landmark study details how an enterprise pediatric remote patient management model expanded from a single cardiology pilot to 16 diverse specialty programs by combining centralized digital operations with specialty clinical leadership.
Today
A comparative review of tension band wiring and intramedullary screw fixation in thumb metacarpophalangeal arthrodesis, evaluating union rates, hardware complications, and clinical outcomes.
Today
A breakthrough ultrathin multimodal sensor decouples physical hemodynamic monitoring from disposable electrochemical calibration, achieving long-term wearable glucose prediction with 81.36% accuracy and a 9.12% MARD. This offers a robust, drift-free solution for outpatient metabolic surveillance.
Today
